FOR AUTHORS
Top of pageDid you know?
- That the millions of users of nature.com can now sign up for an e-mail copy of the table of contents for the Immunology & Cell Biology issue in which your article is published.
- That an academic journal like Immunology & Cell Biology hosted on nature.com has on average over 50,000 page views on their web site per month.
- That Immunology & Cell Biology has an impact factor of 3.033
Submitting an article
To read about how to prepare your article, please click on Instructions for Authors. If you are ready to submit an article please click on Online Submission.
Top of pageBenefits of publishing with Immunology & Cell Biology
Immunology & Cell Biology is committed to publishing high quality, independently peer-reviewed research and review material.
The journal is published in partnership with Nature Publishing Group (NPG), which uses pioneering technologies, innovative formats and world-class production to provide premium information for scientific researchers in the public and private sectors, government agencies and educators.
A key strength of NPG is its close relationship with the scientific community. By working closely with scientists, listening to what they say, and always placing emphasis on quality rather than quantity, NPG is the leading scientific publisher at finding innovative solutions to scientists' information needs, both for the Nature-branded publications and those published on behalf of society partners, including ASI.
Publishing with Immunology & Cell Biology and NPG provides an author with a wide range of benefits:-
Copyright and license to publish
Australasian Society for Immunology Incorporated does not require authors of original research papers to assign copyright of their published contributions. Authors grant Australasian Society for Immunology Incorporated an exclusive license to publish, in return for which they can re-use their papers in their future printed work. NPG's author license page provides details of the policy and a sample form. Authors are encouraged to submit their version of the accepted, peer-reviewed manuscript to their funding body's archive for public release six months after publication. In addition, authors are encouraged to archive their version of the manuscript in their institution's repositories (as well as on their personal websites), also six months after the original publication. Authors should cite the publication reference and doi number on any deposited version, and provide a link from it to the published article on the NPG website. This policy complements the policies of the US National Institutes of Health, the Wellcome Trust and other research funding bodies around the world. NPG recognizes the efforts of funding bodies to increase access of the research they fund, and strongly encourages authors to participate in such efforts.
Online presence - reducing publication times
Immunology & Cell Biology has adopted NPG's online submission system, which allows authors to submit papers via the Web. Speeding up the submission and refereeing process, this system also allows you to view the status of your paper online.
Weekly publication online
New articles in Immunology & Cell Biology, as in all NPG journals, are published weekly online ahead of the archival print issue, ensuring the research is made publicly available and can be cited as soon as possible after acceptance for publication. The online publication is identical to the printed version and is not a preliminary, unedited version, thus maintaining the journal's tradition of excellence and the integrity of the published record.
Supplementary online material
Authors are invited to submit additional supporting material such as data sets or video for publication in the online version of the journal. Online supplementary material makes the most of the Web as a delivery platform and can often give articles greater depth, making them more useful to readers.
Quality
Authors who choose to publish in any NPG journal can be assured that its staff's publishing, editorial and production skills are committed to maintaining the highest possible quality and standards.
Exposure - widest possible readership
All NPG journals, including Immunology & Cell Biology, are available online via site licenses to academic, corporate and government institutions and consortia. Journals are available to members of these institutions at the click of a mouse, adding speed and visibility to authors' research papers.
Regular free e-mail alerts
Content published in Immunology & Cell Biology has the potential to reach scientists around the world who have signed up for NPG's free table of contents e-alerts, ensuring additional exposure to authors. These e-alerts allow recipients to click through to the full article if they subscribe or work at an institution with a site license, or click through to the article's abstract for other readers.
Focused subject areas on nature.com
From immunology to physics, genetics to materials, subject-specific areas provide a focused environment for readers, providing a monthly updated focus for a particular field.
Abstracting and indexing
Immunology & Cell Biology is included in the leading abstracting and indexing services including ISI, MEDLINE, EMBASE and BIOSIS. Extensive reference linking to MEDLINE, ISI, Chemport and others via services such as Crossref and DOI numbers provide seamless online linking between articles and databases.
Media coverage
The Nature press office provides information about exceptionally interesting papers published throughout NPG. More than 2,000 journalists and media organizations worldwide subscribe to the press service, ensuring that papers receive maximum exposure in the world's most important media channels including newspapers, magazines, radio and television.
Extending science further - global collaborations
NPG and Immunology & Cell Biology support some projects aimed at making current research available to a broader community of scientists and practitioners.
All NPG journals, including Immunology & Cell Biology, are in WHO's HINARI (Health InterNetwork Access to Research Initiative) program, which provides free access to public institutions in developing countries.
